Purple Biotech Ltd ADR
(PPBT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 5,122 | 6,601 | 5,081 | 3,590 | 7,331 |
| Operating Income | -5,122 | -6,601 | -5,081 | -3,590 | -7,331 |
| Interest Expense | 59 | -41 | 16 | 51 | 41 |
| Other Income | 278 | 517 | 248 | 89 | 56 |
| Pre-tax Income | -4,903 | -6,043 | -4,849 | -3,552 | -7,316 |
| Net Income Continuous | -4,903 | -6,043 | -4,849 | -3,552 | -7,316 |
| Minority Interests | -25 | -32 | -25 | -16 | -19 |
| Net Income | $-4,878 | $-6,011 | $-4,824 | $-3,536 | $-7,297 |
| EPS Basic Total Ops | -5.00 | -6.40 | -5.40 | -4.00 | -8.20 |
| EPS Basic Continuous Ops | -4.94 | -6.54 | -5.37 | -3.95 | -8.21 |
| EPS Diluted Total Ops | -5.00 | -6.40 | -5.40 | -4.00 | -8.20 |
| EPS Diluted Continuous Ops | -4.94 | -6.54 | -5.37 | -3.95 | -8.21 |
| EBITDA(a) | $-5,076 | $-6,551 | $-5,034 | $-3,537 | $-7,280 |